SCHEMBL22910218

SCHEMBL22910218

c1ccc(-c2nc(-c3ccncc3)nc(-c3ccc(-c4c(-c5ccccc5)ccc5c4-c4ccccc4C5(c4ccccc4)c4ccccc4)cc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.39
MAPT P10636 4/20 0.39
TSHR P16473 3/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
HSD17B10 Q99714 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
LMNA P02545 2/20 0.34
KDM4E B2RXH2 1/20 0.34
OPRK1 P41145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22910308 0.94 MEN1 (0.38) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22910219 0.94 MEN1 (0.38) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22910208 0.92 SMN1; SMN2 (0.36) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22038031 0.90 SMN1; SMN2 (0.41) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22037952 0.90 SMN1; SMN2 (0.41) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22910220 0.90 PDK2 (0.41) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL21351037 0.88 PDK2 (0.42) SMN1; SMN2MAPTTSHRALDH1A1NPC1
SCHEMBL22910225 0.88 L3MBTL1 (0.36) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22910392 0.87 MAPT (0.39) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22910361 0.86 KDM4E (0.40) SMN1; SMN2MAPTTSHRALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569453-B2 Polycyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2023-01-31 US disclosed
US-20210020848-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210020848-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME PPOX, NFE2L2, OGFOD1 SMN1; SMN2 4116/4885MAPT 1709/4885TSHR 4308/4885
US-11569453-B2 Polycyclic compound and organic light emitting element comprising same PPOX, NFE2L2, OGFOD1 SMN1; SMN2 4116/4885MAPT 1709/4885TSHR 4308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.